Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study
Article in Cancers (February 2024)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Article in Cancers (February 2024)
Article in Journal of Clinical Oncology (February 2024)
Book chapter (January 2024)